AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American brain tumor consortium study. (vol 2, pg 34, 2000)
Authors: Schold, SC Kuhn, JG Chang, SM Bosik, ME Robins, HI Mehta, MP Spence, AM Fulton, D Fink, KL Prados, MD
Citation: Sc. Schold et al., A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American brain tumor consortium study. (vol 2, pg 34, 2000), NEURO-ONCOL, 3(2), 2001, pp. 123-123
EGFR overexpression and radiation response in glioblastoma multiforme
Authors: Barker, FG Simmons, ML Chang, SM Prados, MD Larson, DA Sneed, PK Wara, WM Berger, MS Chen, PC Israel, MA Aldape, KD
Citation: Fg. Barker et al., EGFR overexpression and radiation response in glioblastoma multiforme, INT J RAD O, 51(2), 2001, pp. 410-418
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme
Authors: Prados, MD Wara, WM Sneed, PK McDermott, M Chang, SM Rabbitt, J Page, M Malec, M Davis, RL Gutin, PH Lamborn, K Wilson, CB Phillips, TL Larson, DA
Citation: Md. Prados et al., Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme, INT J RAD O, 49(1), 2001, pp. 71-77
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery
Authors: Graves, EE Nelson, SJ Vigneron, DB Verhey, L McDermott, M Larson, D Chang, S Prados, MD Dillon, WP
Citation: Ee. Graves et al., Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery, AM J NEUROR, 22(4), 2001, pp. 613-624
Age and radiation response in glioblastoma multiforme
Authors: Barker, FG Chang, SM Larson, DA Sneed, PK Wara, WM Wilson, CB Prados, MD
Citation: Fg. Barker et al., Age and radiation response in glioblastoma multiforme, NEUROSURGER, 49(6), 2001, pp. 1288-1297
A phase II study of paclitaxel in patients with recurrent malignant gliomausing different doses depending upon the concomitant use of anticonvulsants - A North American Brain Tumor Consortium report
Authors: Chang, SM Kuhn, JG Robins, HI Schold, SC Spence, AM Berger, MS Mehta, MP Pollack, IF Rankin, C Prados, MD
Citation: Sm. Chang et al., A phase II study of paclitaxel in patients with recurrent malignant gliomausing different doses depending upon the concomitant use of anticonvulsants - A North American Brain Tumor Consortium report, CANCER, 91(2), 2001, pp. 417-422
Effect of disease burden on health-related quality of life in patients with malignant gliomas
Authors: Osoba, D Brada, M Prados, MD Yung, WKA
Citation: D. Osoba et al., Effect of disease burden on health-related quality of life in patients with malignant gliomas, NEURO-ONCOL, 2(4), 2000, pp. 221-228
Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine,and vincristine chemotherapy with radiotherapy for treating malignant glioma in children
Authors: Levin, VA Lamborn, K Wara, W Davis, R Edwards, M Rabbitt, J Malec, M Prados, MD
Citation: Va. Levin et al., Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine,and vincristine chemotherapy with radiotherapy for treating malignant glioma in children, NEURO-ONCOL, 2(1), 2000, pp. 22-28
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American Brain Tumor Consortium study
Authors: Schold, SC Kuhn, JG Chang, SM Bosik, ME Robins, HI Mehta, MP Spence, AM Fulton, D Fink, KL Prados, MD
Citation: Sc. Schold et al., A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide:A North American Brain Tumor Consortium study, NEURO-ONCOL, 2(1), 2000, pp. 34-39
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazin N-(2-chloroethyl)-N '-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
Authors: Levin, VA Uhm, JH Jaeckle, KA Choucair, A Flynn, PJ Yung, WKA Prados, MD Bruner, JM Chang, SM Kyritsis, AP Gleason, MJ Hess, KR
Citation: Va. Levin et al., Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazin N-(2-chloroethyl)-N '-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme, CLIN CANC R, 6(10), 2000, pp. 3878-3884
Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide
Authors: Osoba, D Brada, M Yung, WKA Prados, MD
Citation: D. Osoba et al., Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide, EUR J CANC, 36(14), 2000, pp. 1788-1795
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas
Authors: Graves, EE Nelson, SJ Vigneron, DB Chin, C Verhey, L McDermott, M Larson, D Sneed, PK Chang, S Prados, MD Lamborn, K Dillon, WP
Citation: Ee. Graves et al., A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas, NEUROSURGER, 46(2), 2000, pp. 319-326
Biology and treatment of malignant glioma
Authors: Prados, MD Levin, V
Citation: Md. Prados et V. Levin, Biology and treatment of malignant glioma, SEMIN ONCOL, 27(3), 2000, pp. S1-S10
Future directions in the treatment of malignant gliomas with temozolomide
Authors: Prados, MD
Citation: Md. Prados, Future directions in the treatment of malignant gliomas with temozolomide, SEMIN ONCOL, 27(3), 2000, pp. S41-S46
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
Authors: Yung, WKA Albright, RE Olson, J Fredericks, R Fink, K Prados, MD Brada, M Spence, A Hohl, RJ Shapiro, W Glantz, M Greenberg, H Selker, RG Vick, NA Rampling, R Friedman, H Phillips, P Bruner, J Yue, N Osoba, D Zaknoen, S Levin, VA
Citation: Wka. Yung et al., A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse, BR J CANC, 83(5), 2000, pp. 588-593
Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: Correlation with radiation treatment outcome
Authors: Huhn, SL Mohapatra, G Bollen, A Lamborn, K Prados, MD Feuerstein, BG
Citation: Sl. Huhn et al., Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: Correlation with radiation treatment outcome, CLIN CANC R, 5(6), 1999, pp. 1435-1443
The role of paclitaxel in the treatment of primary and metastatic brain tumors
Authors: Glantz, MJ Chamberlain, MC Chang, SM Prados, MD Cole, BF
Citation: Mj. Glantz et al., The role of paclitaxel in the treatment of primary and metastatic brain tumors, SEM RAD ONC, 9(2), 1999, pp. 27-33
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
Authors: Yung, WKA Prados, MD Yaya-Tur, R Rosenfeld, SS Brada, M Friedman, HS Albright, R Olson, J Chang, SM O'Neill, AM Friedman, AH Bruner, J Yue, N Dugan, M Zaknoen, S Levin, VA
Citation: Wka. Yung et al., Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse, J CL ONCOL, 17(9), 1999, pp. 2762-2771
Outcomes and prognostic factors in recurrent glioma patients enrolled ontophase II clinical trials
Authors: Wong, ET Hess, KR Gleason, MJ Jaeckle, KA Kyritsis, AP Prados, MD Levin, VA Yung, WKA
Citation: Et. Wong et al., Outcomes and prognostic factors in recurrent glioma patients enrolled ontophase II clinical trials, J CL ONCOL, 17(8), 1999, pp. 2572-2578
Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American brain tumor consortium report
Authors: Chang, SM Kuhn, JG Robins, HI Schold, SC Spence, AM Berger, MS Mehta, MP Bozik, ME Pollack, I Schiff, D Gilbert, M Rankin, C Prados, MD
Citation: Sm. Chang et al., Phase II study of phenylacetate in patients with recurrent malignant glioma: A North American brain tumor consortium report, J CL ONCOL, 17(3), 1999, pp. 984-990
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplasticastrocytoma: A retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy
Authors: Prados, MD Scott, C Curran, WJ Nelson, DF Leibel, S Kramer, S
Citation: Md. Prados et al., Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplasticastrocytoma: A retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy, J CL ONCOL, 17(11), 1999, pp. 3389-3395
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: A preliminary report of RTOG 9404
Authors: Prados, MD Scott, C Sandler, H Buckner, JC Phillips, T Schultz, C Urtasun, R Davis, R Gutin, P Cascino, TL Greenberg, HS Curran, WJ
Citation: Md. Prados et al., A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: A preliminary report of RTOG 9404, INT J RAD O, 45(5), 1999, pp. 1109-1115
Late radiation injury following hyperfractionated craniospinal radiotherapy for primitive neuroectodermal tumor
Authors: Russo, C Fischbein, N Grant, E Prados, MD
Citation: C. Russo et al., Late radiation injury following hyperfractionated craniospinal radiotherapy for primitive neuroectodermal tumor, INT J RAD O, 44(1), 1999, pp. 85-90
Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Results of a phase II study
Authors: Prados, MD Edwards, MSB Chang, SM Russo, C Davis, R Rabbitt, J Page, M Lamborn, K Wara, WM
Citation: Md. Prados et al., Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Results of a phase II study, INT J RAD O, 43(2), 1999, pp. 279-285
Radiopotentiation of human brain tumor cells by sodium phenylacetate
Authors: Ozawa, T Lu, RM Hu, LJ Lamborn, KR Prados, MD Deen, DF
Citation: T. Ozawa et al., Radiopotentiation of human brain tumor cells by sodium phenylacetate, CANCER LETT, 142(2), 1999, pp. 139-146
Risultati: 1-25 | 26-26